BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 31, 2010
View Archived Issues
Preclinical studies support investigation of CEM-101 in COPD
Read More
TEI-3252 identified as bifunctional bronchodilator
Read More
LX-1031 alleviates disease symptoms in phase II trial in IBS
Read More
UFD1L gene SNP correlates with early-onset schizophrenia
Read More
Favorable data presented on riociguat in pulmonary hypertension
Read More
AM-206 improves symptoms of allergic rhinitis in vivo
Read More
Tranexamic acid tablets reduce menstrual blood loss in clinical trials
Read More
Galderma claims new melanocortin MC4 receptor antagonists
Read More
NeuroSearch claims new K(V)7 potassium channel activators
Read More
Organon claims new HCN channel-modulating analgesics
Read More
Shanghai Genomics claims new protein kinase inhibitors
Read More
Funxional Therapeutics raises funds for phase II FX-125L trials in inflammation
Read More
AstraZeneca reports developments for first quarter 2010
Read More
NICE issues recommendation for somatropin products, including Omnitrope
Read More
New phase II data disclosed on simplified Visonac procedure
Read More
CrystalGenomics merges with BexPharm
Read More
Advanced Life Sciences expands Restanza collaboration with U.S. government
Read More
Pfizer halts Inspra trial early after significant benefit is shown
Read More
Bionomics provides overview of clinical programs
Read More
Prolia obtains marketing authorization in E.U.
Read More
Vertex identifies new ABC transporter modulators
Read More
FDA committee recommends approval of tesamorelin
Read More
NewLink begins phase III HyperAcute-Pancreas immunotherapy trial
Read More
CSL Behring gains national marketing authorizations for Berinert
Read More
Two phase III Heplisav trials cleared to continue immunizations
Read More
FDA and EMA approve reanalysis of images from phase III RG-1068 trial
Read More
Short-acting anesthetic/sedative CNS-7056 enters phase IIb trial
Read More